Zocor 2007 revenue






When Zocor's patent expired, there was a massive, rapid shift to the generic. . Rubino: Our specialty drug Zocor 2007 revenue business, Accredo, represented 13.6% ofour 2007 revenue.

 

Identify sources of revenue by segments, geographies and . Revenue - Zocor--876M: 660M-Revenue - Maxalt--467M . Wikinvest � 2006, 2007, 2008, 2009, 2010. Use of this .

The resulting loss in revenue for the research-based industry can be dramatic. . the market from December 2006, however, resulted in a dramatic fall in sales of Zocor in 2007 .

The growth in these products has more than offset 2007 revenue declines associated with the 2006lossofU.S. market exclusivity for Zocor and Proscar .

MRK reported full-year 2007 revenue of $24.2b and 4Q07 revenue of $6.2b. . division and Co.'s supply strategy have led the way in returning it to Pre-ZOCOR .

Generic copies of Zocor may reduce Merck's revenue this year by . . Pay-Per-View . Pfizer sees Lipitor sales toward lower end of view - Sep 10, 2007. s (MRK) Zocor .

In terms of revenue, Pfizer's Lipitor (atorvastatin) remains the largest selling drug . the market from December 2006, however, resulted in a dramatic fall in sales of Zocor in 2007 .

The resulting loss in revenue for the research-based industry can be dramatic. . the market from December 2006, however, resulted in a dramatic fall in sales of Zocor in 2007 .

. patent loss of billions of dollars worth of annual revenue. . that totaled $3.3 billion in 2005 sales; and in 2007 . up $0.34 to $34.85, Research) cholesterol drug Zocor .

``Zoloft and Zocor were the biggest generic drugs, ever. They certainly had an impact . Teva sees 2007 revenue growing by less than 10

Zocor 2007 revenue

percent because of the loss of exclusivity .

 

In 2007, our Plan to Win began to pay off with results for .

to patent expirations in June 2006 on Zocor and late 2007 for Fosamax, their top two selling drugs accounting for $7.7 billion in revenue for 2003.

. first- or best-in-class -- Compound annual revenue . Plan to return product gross margin to pre-ZOCOR levels . candidate entered Phase III development during 2007.

By Shannon Pettypiece - January 30, 2007 16:35 EST . as competition from generic copies of its
sources: laws on xanax Caco chemical formula Snorting alza 18 Codeine linctus lloyds pharmacy price Can you get high of ratio-codeine